Research Paper Volume 15, Issue 6 pp 2221—2236

Promising antitumor effects of the curcumin analog DMC-BH on colorectal cancer cells

class="figure-viewer-img"

Figure 6. DMC-BH inhibits the growth of xenografts derived from HCT116 and HT-29 cells. (A) Volumes of xenografts derived from CRC cells treated with 20 mg/kg DMC-BH or curcumin. (B) Xenograft weights of CRC cells treated with 20 mg/kg DMC-BH or curcumin. (C) Immunohistochemical analysis of p-AKT and p-mTOR expression in xenografts.